Image
As the number of approved gene and cellular therapies grows, you can start preparing your organization now by taking the right next steps.
Encouraging genomic testing is critical to identifying lung cancer patients who would benefit from targeted therapy.
Improving access to regular cervical cancer screenings, especially for women in underserved communities, is key to reducing mortality rates.